Pfizer and Bio NTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October , Bio NTech CEO and co founder Ugur Sahin has told CNN . 
" It has an excellent profile and I consider this vaccine ... near perfect , and which has a near perfect profile , " Sahin said in an exclusive interview with CNN . 
He added that the company 's " understanding of the mode of action , in combination with the safety data coming in from the running trial " meant that they have " a lot of confidence " in it . 
" Yes , we believe that we have a safe product and we believe that we will be able to show efficacy , " he said . 
Sahin told CNN he believes that approval for emergency use will be granted quickly by regulatory authorities . 
US drug giant Pfizer and German firm Bio NTech say they plan to provide 100 million doses of their vaccine candidate , BNT162 , by the end of the year , and up to 1.3 billion doses in 2021 . 
Watch : 
